Drug could be a ‘game-changer’ for millions with chronic coughs

British researchers found gefapixant reduces coughing by 60 per cent, improves chronic sufferers’ sleep and reduces chest pain. It would be the first new cough treatment in 50 years if approved.British researchers found gefapixant reduces coughing by 60 per cent, improves chronic sufferers’ sleep and reduces chest pain. It would be the first new cough treatment in 50 years if approved.Read MoreHealth News | Mail Online